scholarly journals Molecular Mechanism of Capsid Disassembly in Hepatitis B Virus

2021 ◽  
Author(s):  
Zhaleh Ghaemi ◽  
Martin Gruebele ◽  
Emad Tajkhorshid

AbstractThe disassembly of a viral capsid leading to the release of its genetic material into the host cell is a fundamental step in viral infection. Hepatitis B virus (HBV) in particular consists of identical capsid protein monomers that dimerize and also arrange themselves into pentamers or hexamers on the capsid surface. By applying atomistic molecular dynamics simulation to an entire solvated HBV capsid subject to a uniform mechanical stress protocol, we monitor the disassembly process down to the level of individual amino acids. The strain of an external force combined with thermal fluctuations causes structurally heterogeneous cracks to appear in the HBV capsid. Unlike the expectation from purely mechanical considerations, the cracks mainly occur within and between hexameric sites, whereas pentameric sites remain largely intact. Only a small subset of the capsid protein monomers governs disassembly. These monomers are distributed across the whole capsid, but belong to regions with a high degree of collective motion that we label ‘communities’. Cross-talk within these communities is a mechanism of crack propagation leading to destabilization of the entire capsid, and eventually its disassembly. We identify specific residues whose interactions are most readily lost during disassembly: R127, I139, Y132, N136, A137, and V149 are among the hotspots at the interfaces between dimers that lie within or span hexamers, leading to dissociation. The majority of these hotspots are evolutionary conserved, indicating that they are important for disassembly by avoiding over-stabilization of capsids.SignificanceHepatitis B virus (HBV) is a DNA virus that is 100 times more infectious than HIV. Despite the availability of a vaccine, the chronic infection rate of this virus is still about 300 million people globally. HBV chronic infection, for which no cure is currently available, can lead to liver cancer. Therefore, there is an unmet need to investigate the infection cycle of the virus. One of the most crucial steps in virus replication cycle is the release of its genetic material to the nucleus. During this step, the viral capsid enclosing the genetic material disassembles. However, its mechanism is unknown. Here, we utilize molecular simulations to shed light on the events leading to the capsid disassembly with atomistic detail.

2021 ◽  
Vol 118 (36) ◽  
pp. e2102530118
Author(s):  
Zhaleh Ghaemi ◽  
Martin Gruebele ◽  
Emad Tajkhorshid

The disassembly of a viral capsid leading to the release of its genetic material into the host cell is a fundamental step in viral infection. In hepatitis B virus (HBV), the capsid consists of identical protein monomers that dimerize and then arrange themselves into pentamers or hexamers on the capsid surface. By applying atomistic molecular dynamics simulation to an entire solvated HBV capsid subjected to a uniform mechanical stress protocol, we monitor the capsid-disassembly process and analyze the process down to the level of individual amino acids in 20 independent simulation replicas. The strain of an isotropic external force, combined with structural fluctuations, causes structurally heterogeneous cracks to appear in the HBV capsid. Analysis of the monomer–monomer interfaces reveals that, in contrast to the expectation from purely mechanical considerations, the cracks mainly occur within hexameric sites, whereas pentameric sites remain largely intact. Only a small subset of the capsid protein monomers, different in each simulation, are engaged in each instance of disassembly. We identify specific residues whose interactions are most readily lost during disassembly; R127, I139, Y132, N136, A137, and V149 are among the hot spots at the interfaces between dimers that lie within hexamers, leading to disassembly. The majority of these hot-spot residues are conserved by evolution, hinting to their importance for disassembly by avoiding overstabilization of capsids.


2017 ◽  
Vol 7 (1) ◽  
Author(s):  
Masashi Iwamoto ◽  
Dawei Cai ◽  
Masaya Sugiyama ◽  
Ryosuke Suzuki ◽  
Hideki Aizaki ◽  
...  

1997 ◽  
Vol 43 (8) ◽  
pp. 1500-1506 ◽  
Author(s):  
Norman Gitlin

Abstract Hepatitis B virus (HBV) infection occurs worldwide and is an important cause of acute and chronic viral hepatitis in the US. In this review, I describe the virus, risk factors for infection, clinical features of infection, results of laboratory tests during infection, and standard and emerging treatment for chronic infection. Although 95% of adult patients recover completely from HBV infection, 90% of children ≤4 years of age develop chronic infection. Active vaccination is highly efficacious.


Author(s):  
Katrina A. Lythgoe ◽  
Sheila F. Lumley ◽  
Jane A. McKeating ◽  
Philippa C. Matthews

AbstractHepatitis B virus (HBV) infection is a major global health problem with over 240 million infected individuals at risk of developing progressive liver disease and hepatocellular carcinoma. HBV is an enveloped DNA virus that establishes its genome as an episomal, covalently closed circular DNA (cccDNA) in the nucleus of infected hepatocytes. Currently available standard-of-care treatments for chronic hepatitis B (CHB) include nucleos(t)ide analogues (NA) that suppress HBV replication but do not target the cccDNA and hence rarely cure infection. There is considerable interest in determining the lifespan of cccDNA molecules to design and evaluate new curative treatments. We took a novel approach to this problem by developing a new mathematical framework to model changes in evolutionary rates during infection which, combined with previously determined within-host evolutionary rates of HBV, we used to determine the lifespan of cccDNA. We estimate that during HBe-antigen positive (HBeAgPOS) infection the cccDNA lifespan is 61 (36-236) days, whereas during the HBeAgNEG phase of infection it is only 26 (16-81) days. We found that cccDNA replicative capacity declined by an order of magnitude between HBeAgPOS and HBeAgNEG phases of infection. Our estimated lifespan of cccDNA is too short to explain the long durations of chronic infection observed in patients on NA treatment, suggesting that either a sub-population of long-lived hepatocytes harbouring cccDNA molecules persists during therapy, or that NA therapy does not suppress all viral replication. These results provide a greater understanding of the biology of the cccDNA reservoir and can aid the development of new curative therapeutic strategies for treating CHB.


1996 ◽  
Vol 49 (2) ◽  
pp. 103-109 ◽  
Author(s):  
Akihiko Okumura ◽  
Masahiro Takayanagi ◽  
Toshiyuki Aiyama ◽  
Kazuo Iwata ◽  
Takaji Wakita ◽  
...  

2010 ◽  
Vol 82 (3) ◽  
pp. 371-378 ◽  
Author(s):  
Ding-Qiang Chen ◽  
Yong Zeng ◽  
Jie Zhou ◽  
Ling Yang ◽  
Shibo Jiang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document